Across TCGA pan-cancer cohorts, MYL6BP1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MYL6BP1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MYL6BP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MYL6BP1 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

STAD, BRCA, and THCA are the cancer types where MYL6BP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MYL6BP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.102	.001	3	view →
BRCA	All	III,IV	−0.044	.039	2	view →
THCA	Female	III,IV	−0.049	.023	1	view →
LIHC	Female	All	+0.022	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MYL6BP1 RNA expression & survival · all MYL6BP1 data types